Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-12 12:59:19 UTC, with 39 holding rows worth $373,391,375.

Accession
0001381843-26-000013
Filed
2026-11-12
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 39 entries on the cover page, a total value of $373,391,375 stated on the cover page (in dollars after the unit check, H1), rows summing to $373,391,375 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Eli Lilly and Company532457108COM31,202$36,103,210dollars as filed
Merck & Co.,Inc.58933Y105COM168,987$24,555,501dollars as filed
Johnson & Johnson478160104COM91,387$24,193,794dollars as filed
AbbVie,Inc.00287Y109COM91,294$23,881,597dollars as filed
Thermo Fisher Scientific Inc.883556102COM34,410$23,228,471dollars as filed
BIOGEN INC COM09062X103Stock70,955$16,027,315dollars as filed
Vertex Pharmaceuticals Incorporated92532F100COM28,157$14,720,761dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock66,113$13,570,354dollars as filed
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR35,679$13,056,373dollars as filed
CVS Health Corporation126650100COM139,311$11,937,560dollars as filed
CENCORA INC COM03073E105Stock36,107$10,841,127dollars as filed
BRIDGEBIO PHARMA INC10806X102COM163,697$10,771,263dollars as filed
Intuitive Surgical,Inc.46120E602COM25,648$10,429,246dollars as filed
INSMED INC COM PAR $.01457669307Stock87,469$9,983,712dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock109,647$9,464,729dollars as filed
Stryker Corporation863667101COM34,296$9,444,775dollars as filed
INCYTE CORP COM45337C102Stock77,377$9,389,699dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock28,074$9,336,289dollars as filed
DEXCOM INC COM252131107Stock89,251$7,701,469dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK303,824$7,389,000dollars as filed
IRHYTHM HOLDINGS INC COM450056106Stock54,102$6,149,233dollars as filed
Gilead Sciences,Inc.375558103COM40,461$6,030,712dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM70,071$5,989,669dollars as filed
CARDINAL HEALTH INC14149Y108COM26,735$5,948,538dollars as filed
Boston Scientific Corporation101137107COM130,622$5,701,650dollars as filed
ALKERMES PLCG01767105SHS136,225$5,519,837dollars as filed
NEUROCRINE BIOSCIENCES INC64125C109COM38,611$5,476,584dollars as filed
TANGO THERAPEUTICS INC87583X109COM184,394$4,600,630dollars as filed
ABIVAX SA-00370M103SPONSORED ADS46,452$4,599,677dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW44,243$3,938,954dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock43,180$3,596,462dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock93,550$3,594,191dollars as filed
SUMMIT THERAPEUTICS INC86627T108COM184,687$3,123,057dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS243,506$3,029,215dollars as filed
DISC MEDICINE INC COM254604101Stock43,682$2,859,424dollars as filed
CELCUITY INC15102K100COM29,893$2,377,091dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK14,924$2,058,467dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock663,772$1,546,589dollars as filed
VERADERMICS INC922967104COMMON STOCK10,106$1,225,150dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001381843-26-000013this filing2026-11-12